| Depressing mitochondria-reticulum interactions protects cardiomyocytes from lethal hypoxia-reoxygenation injury M Paillard, E Tubbs, PA Thiebaut, L Gomez, J Fauconnier, ... Circulation 128 (14), 1555-1565, 2013 | 272 | 2013 |
| Therapeutic potential of NADPH oxidase 1/4 inhibitors G Teixeira, C Szyndralewiez, S Molango, S Carnesecchi, F Heitz, ... British journal of pharmacology 174 (12), 1647-1669, 2017 | 171 | 2017 |
| Disruption of calcium transfer from ER to mitochondria links alterations of mitochondria-associated ER membrane integrity to hepatic insulin resistance J Rieusset, J Fauconnier, M Paillard, E Belaidi, E Tubbs, MA Chauvin, ... Diabetologia 59, 614-623, 2016 | 152 | 2016 |
| A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection L Gomez, M Paillard, M Price, Q Chen, G Teixeira, S Spiegel, ... Basic research in cardiology 106, 1341-1353, 2011 | 92 | 2011 |
| Cardiac fibroblasts protect cardiomyocytes against lethal ischemia–reperfusion injury M Abrial, CC Da Silva, B Pillot, L Augeul, F Ivanes, G Teixeira, R Cartier, ... Journal of molecular and cellular cardiology 68, 56-65, 2014 | 85 | 2014 |
| mTOR inactivation in myocardium from infant mice rapidly leads to dilated cardiomyopathy due to translation defects and p53/JNK-mediated apoptosis L Mazelin, B Panthu, AS Nicot, E Belotti, L Tintignac, G Teixeira, Q Zhang, ... Journal of molecular and cellular cardiology 97, 213-225, 2016 | 59 | 2016 |
| Synergistic protective effect of cyclosporin A and rotenone against hypoxia–reoxygenation in cardiomyocytes G Teixeira, M Abrial, K Portier, P Chiari, E Couture-Lepetit, Y Tourneur, ... Journal of molecular and cellular cardiology 56, 55-62, 2013 | 50 | 2013 |
| Cyclosporine A at reperfusion fails to reduce infarct size in the in vivo rat heart D De Paulis, P Chiari, G Teixeira, E Couture-Lepetit, M Abrial, L Argaud, ... Basic research in cardiology 108, 1-11, 2013 | 46 | 2013 |
| Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment N Roehlen, M Muller, Z Nehme, E Crouchet, F Jühling, F Del Zompo, ... Journal of Hepatology 78 (2), 343-355, 2023 | 28 | 2023 |
| A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity N Roehlen, A Saviano, H El Saghire, E Crouchet, Z Nehme, F Del Zompo, ... Science translational medicine 14 (676), eabj4221, 2022 | 27 | 2022 |
| Involvement of cyclophilin D and calcium in isoflurane-induced preconditioning G Teixeira, P Chiari, J Fauconnier, M Abrial, E Couture-Lepetit, ... Anesthesiology 123 (6), 1374-1384, 2015 | 14 | 2015 |
| Disruption of cyclophilin D-mediated calcium transfer from the ER to mitochondria contributes to hepatic ER stress and insulin resistance J Rieusset, J Fauconnier, M Paillard, E Belaidi, E Tubbs, MA Chauvin, ... Hepatology, 2012 | 9 | 2012 |
| 476 Mewton N, Belaidi E, Durand A, Abrial M, Lacampagne A, Rieusset J, Ovize M. 477 Depressing mitochondria-reticulum interactions protects cardiomyocytes from lethal hypoxia … M Paillard, E Tubbs, PA Thiebaut, L Gomez, J Fauconnier, CC Da Silva, ... Circulation 128 (1555-1565), 479, 2013 | 6 | 2013 |
| # 2837 Novel therapeutic for crescentic glomerulonephritis through targeting CLDN1 in parietal epithelial cells JD Delbet, V Anquetil, K Saitoski, A Toso, T Baumert, S Toovey, L Manenti, ... Nephrology Dialysis Transplantation 39 (Supplement_1), gfae069-0018-2837, 2024 | 1 | 2024 |
| Claudin-1 Is a Therapeutic Target for Crescentic Glomerulonephritis: TH-PO531 G Teixeira, JD Delbet, V Anquetil, A Toso, S Toovey, L Manenti, R Iacone, ... Journal of the American Society of Nephrology 34 (11S), 238, 2023 | 1 | 2023 |
| Abstract LB284: CLAUDIN-1 targeting antibody ALE. C04 drives single activity and restores anti-PD1 efficacy in solid tumors A Toso, G Teixeira, T Zimmermann, SG Gill, D Schmitter, M Meyer, ... Cancer Research 83 (8_Supplement), LB284-LB284, 2023 | 1 | 2023 |
| OS-040-YI Claudin-1 is a mediator and therapeutic target of biliary fibrosis by modulating liver progenitor cell fate and signaling F Del Zompo, E Crouchet, T Ostyn, F Jühling, J Moehlin, N Roehlen, ... Journal of Hepatology 80, S31-S32, 2024 | | 2024 |
| Expression of Exposed CLDN1 Is Linked to Early Pathological Lesions in Idiopathic Pulmonary Fibrosis EE Cortesi, V Anquetil, JE Mcdonough, B Weynand, A Vanstapel, ... A69. PATHOGENESIS OF INTERSTITIAL AND PLEURAL DISEASES, A2508-A2508, 2024 | | 2024 |
| Exploring the Critical Role of Tight Junction Proteins in Kidney Disease Pathogenesis D Jayne, C Herbert, V Anquetil, G Teixeira Nephron, 1-42, 2024 | | 2024 |
| CLAUDIN-1 IS A MEDIATOR AND THERAPEUTIC TARGET FOR CHOLANGIOPATHIES F Del Zompo, E Crouchet, T Ostyn, F Juehling, M Muller, N Roehlen, ... Hepatology 78, S1785-S1786, 2023 | | 2023 |
Maryline AbrialMassachusetts General Hospital - Harvard Medical SchoolAdresse e-mail validée de mgh.harvard.edu